Pegstim Injection (Pegfilgrastim) stimulates white blood cell production in patients undergoing chemotherapy. It helps prevent infections caused by low neutrophil counts. Moreover, clinical studies demonstrate its effectiveness and safety. For more detailed information, check WebMD or PubMed.

Key Benefits & Uses:

• Increases neutrophil counts, reducing infection risk after chemotherapy.

• Offers a single-dose regimen, which improves convenience over daily injections.

• Treats chemotherapy-induced neutropenia and may assist in radiation-induced neutropenia.

• Supports faster recovery and lowers hospitalization risk.

For more guidance, visit Healthline and WHO.

How to Use:
Administer Pegstim as a single subcutaneous injection, usually 24 hours after chemotherapy and at least 14 days before the next cycle. Healthcare professionals typically provide the injection, but patients can learn to self-administer at home. Follow your provider’s instructions carefully to ensure maximum effectiveness.

Important Safety Information:

• Avoid Pegstim if you have severe allergies to pegfilgrastim or filgrastim.

• Watch for serious side effects, including capillary leak syndrome, splenic rupture, and acute respiratory distress.

• Contact your doctor immediately if you notice infection signs, unusual bleeding, or severe bone pain.

Common Side Effects:

• Bone or joint pain

• Headache

• Fatigue

• Nausea

For a complete list of side effects, see Mayo Clinic.

Why Choose Pegstim Injection:

• It provides a convenient single-dose alternative to daily injections.

• Offers a cost-effective biosimilar option to Neulasta without compromising efficacy.

• Clinical studies confirm it lowers infection risk effectively.

For more resources, visit FDA, Mayo Clinic, and Drugs.com.